The magnitude of the neutralization titers against the early pre-treatment virus peaked at week 8 and then decreased slightly by week 24. virologic controllers. The highest levels of contemporaneous autologous neutralizing antibody activity were recognized in the virologic controllers, and a subsequent escape mutation developed within the envelope gene of one controller that abrogated the […]